semaglutide / tirzepatide vs. Semaglutide: Which Weight Loss Medication Is Right for You? Semaglutide, tirzepatide recommended as first-line

Importantly, semaglutide is not recommended for patients with severe gastrointestinal disease or gastroparesis

Look Better & Feel Better Today Let our team help you on your aesthetic journey

Regulatory considerations and legal status The regulatory landscape around tirzepatide has shifted dramatically

Europe is expected to grow significantly in the market during the forecast period

How Semaglutide Dosing Works in Clinical Practice Semaglutide therapy begins at a low starting dose, typically 0.25 mg weekly, then increases gradually over 4 weeks until reaching a therapeutic maintenance dose

If you stop taking Wegovy, the medication will gradually leave your system over 57 weeks, and you may regain weight or see a return of metabolic conditions